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ApoptosisAdenoviral vectors are highly efﬁcient at transferring genes into cells and are broadly used in cancer gene
therapy. However, many therapeutic genes are toxic to vector host cells and thus inhibit vector production.
The truncated form of E2F-1 (E2Ftr), which lacks the transactivation domain, can signiﬁcantly induce cancer
cell apoptosis, but is also toxic to HEK-293 cells and inhibits adenovirus replication. To overcome this, we
have developed binary- and single-vector systems with a modiﬁed tetracycline-off inducible promoter to
control E2Ftr expression. We compared several vectors and found that the structure of expression cassettes
in vectors signiﬁcantly affects E2Ftr expression. One construct expresses high levels of inducible E2Ftr and
efﬁciently causes apoptotic cancer cell death by activation of caspase-3. The approach developed in this
study may be applied in other viral vectors for encoding therapeutic genes that are toxic to their host cells
and/or inhibit vector propagation.
© 2009 Elsevier Inc. All rights reserved.Introduction
Adenovirus (Ad) is easy to manipulate in vitro, produces high titer
stocks, and infects a broad range of mammalian cells. For these
reasons, Ad vectors (Adv) are preferred in basic and medical research.
For cancer gene therapy, Adv are used to deliver genes or modiﬁed
versions of genes into tumors. The products of therapeutic genes are
generally toxic to cancer cells or cause apoptosis; thus, the gene
products may be also toxic to human embryonic kidney HEK-293 cells
used for Adv production and prevention of vector construction and
ampliﬁcation.
The transcription factor E2F-1 plays important roles in the
activation of expression of genes involved in cell cycle progression
and growth. Recent studies by us and others have shown that Adv
expressing E2F-1 efﬁciently induce apoptosis in cancer cells in vitro
and in vivo (Dong et al., 1999, 2002; Elliott et al., 2001; Itoshima et al.,contacted at Department of
ille, KY 40292, USA. H.S. Zhou,
ville Medical School, Louisville,
cMasters),
ll rights reserved.2000; Vorburger et al., 2005). However, the oncogenic property of
promoting cell proliferation by wild type (wt) E2F-1, presumably by
virtue of its ability to stimulate expression of cell cycle-promoting
genes, limits its application in cancer gene therapy. To circumvent this
barrier, the truncated forms of E2F-1 (E2Ftr) were generated, which
lack the transactivation domain and cell cycle-promoting effects (Bell
et al., 2006; Fan and Bertino, 1997). Studies have showed that these
mutants are potent inducers of apoptosis but are unable to induce cell
cycle progression (Fan and Bertino, 1997; Hsieh et al., 1997; Melillo et
al., 1994).
We previously attempted to create an Adv using the Cytomega-
lovirus (CMV) promoter to control E2Ftr (aa 1–375) without success
despite multiple tries (Xiao-Mei Rao, unpublished results), likely
because a high level of E2Ftr is toxic to HEK-293 cells and blocks Ad
replication. To overcome this, we applied a tetracycline (Tet)-off
inducible expression promoter (Gossen and Bujard, 1992) and
developed inducible binary- and single-Adv systems to express
E2Ftr (Fig. 1). Our binary-vector system consists of two vectors: an
Ad helper virus (Adhv) and an Ad-E2Ftr vector. Adhv expresses Tet-
regulated transactivator (tTA), which activates the E2Ftr expression
cassette in Ad-E2Ftr. Without the helper vector, E2Ftr expression in
Ad-E2Ftr is totally inhibited, so Ad-E2Ftr can be created and
ampliﬁed in HEK-293 cells. High levels of the apoptotic E2Ftr protein
are induced in cells only when Adhv is applied with Ad-E2Ftr.
Fig. 1. Schematic diagram of binary- and single-Adv systems. (A) CMV promoter drives the expression of the tTA protein. EGFP or E2Ftr is under the control of a synthetic minimal
promoter composed of Tet-responsive element (TRE) and CMVmini-promoter (phcmv), which is silent unless activated by tTA. In the absence of Tet or Dox, tTA binds to phcmv and
triggers the expression of EGFP or E2Ftr. When Tet is added to the medium, tTA is bound by Tet and unable to bind to phcmv and activate the expression of EGFP or E2Ftr. SK-MEL-2
cells in the absence or presence of Dox (1 μg/ml) were infected with AdTet-EGFP at an MOI of 50. After 24 h, cells were observed for EGFP expression under ﬂuorescence microscopy
and photographs were taken with Kodak MDS 290 software at ×20 magniﬁcation. (B) Schema of three single bicistronic Ads encoding E2Ftr, the left and right inverted terminal
repeat sequences (LITR or RITR, respectively); encapsidation signal (ES) and E1/E3 deleted genes are shown in the Ad structure.
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useful in research, the absolute need for co-delivery of two separate
vectors made the clinical use of this strategy untenable. Thus, we
further developed a single-vector system in which both the tTA and
E2Ftr expression cassettes are incorporated into one Adv. A helper
vector is not required for E2Ftr expression in the single-vector
system.
We compared the binary- and single-vector systems expressing
inducible E2Ftr. We found that Ad-mediated high-level expression of
E2Ftr is toxic to cancer cells as well as to vector host HEK-293 cells.
E2Ftr efﬁciently induces cell death associated with poly (ADP-Ribose)
polymerase (PARP) cleavage and procaspase-3 decrease, the hall-
marks of apoptosis. Since many other genes which have potential for
cancer therapymay be also toxic to vector host cells and inhibit vector
production, the approaches reported in this study may have broad
applications in creation of viral vectors that will carry toxic cancer
therapeutic genes.
Results
Binary- and single-vector systems
Fig. 1A depicts the binary- and single-vector systems with Tet-off
inducible transcription cassettes. In the bi-vector system, expression
of E2Ftr from Ad-E2Ftr is controlled by the Tet-regulating promoter(phcmv), which is activated by tTA encoded in the helper vector Adhv.
In the single-vector system, both transgene and tTA expression
cassettes are inserted in the same vector. Expression of the enhanced
green ﬂuorescent protein (EGFP) reporter shows the efﬁcient
regulation of the Tet-off inducible promoter in the single-vector
system (Fig. 1A). Fig. 1B shows the schema of three different single
bicistronic Adv encoding E2Ftr under the regulation of the Tet-off
system. We did not insert a poly A signal in AdTet-E2Ftr1 because the
Ad's backbone can provide the viral E1 gene poly A signal. The tTA and
E2Ftr expression cassettes in AdTet-E2Ftr2 are closely connected;
while a 400-base pair (bp) fragment from the pcDNA3.1 (+/−)
plasmid (Invitrogen, Carlsbad, CA) was inserted between the two
cassettes in AdTet-E2Ftr3.
Regulation of E2Ftr expression in binary and single Adv
Human melanoma SK-MEL-2 cells were infected with Ad-E2Ftr
alone (control) or co-infected with Adhv in the presence or absence of
doxycycline (Dox; 1 μg/ml), a derivative of Tet. At 48 h after infection,
E2Ftr expression was analyzed. E2Ftr expression from the binary
systemwas only induced in the presence of Adhv and absence of Dox;
adding Dox negatively regulated E2Ftr expression in cells (Fig. 2A).
We further evaluated E2Ftr expression from the three constructs of
the single-vector system. SK-MEL-2 cells were infected with AdTet-
E2Ftr1, AdTet-E2Ftr2, or AdTet-E2Ftr3 at a multiplicity of infection
Fig. 2. Regulation of E2Ftr expression from binary- and single-Adv systems. (A) SK-
MEL-2 cells in the absence or presence of Dox (1 μg/ml) were infected with Ad-E2Ftr at
an MOI of 50 or co-infected with Adhv at an MOI of 5. After 48 h, cells were harvested
and protein extracts were used for a western blot assay. (B) SK-MEL-2 cells in the
absence or presence of Dox (1 μg/ml) were infected with AdTet-E2Ftr1, AdTet-E2Ftr2,
and AdTet-E2Ftr3 at an MOI of 50. After 48 h, cells were harvested and protein extracts
were used for a western blot assay. (C) SK-MEL-2 cells in the absence or presence of Dox
(1 μg/ml) were co-infected with AdTet-E2Ftr1, AdTet-E2Ftr2, and AdTet-E2Ftr3 at an
MOI of 50 and Adhv at an MOI of 5. After 48 h, cells were harvested, protein extracts
were used for a western blot assay, and a mAb mouse-antihuman E2F-1 was used to
detect E2Ftr. α-Actin was used to demonstrate equal loading for each lane. Similar
results were obtained in two additional experiments.
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AdTet-E2Ftr1 and AdTet-E2Ftr2 expressed relatively lower levels of
E2Ftr while AdTet-E2Ftr3 expressed a signiﬁcantly high level of E2Ftr
in the absence of Dox (Fig. 2B). Similar to the binary-vector system,
adding 1 μg/ml of Dox in culture repressed E2Ftr expression in cells
infected with AdTet-E2Ftr1, AdTet-E2Ftr2 or AdTet-E2Ftr3 (Fig. 2B).
These data show that E2Ftr expression can be regulated with Dox in
both single- and binary-vector systems.Fig. 2B shows that AdTet-E2Ftr1 and AdTet-E2Ftr2 expressed
much lower levels of E2Ftr in cancer cells compared to AdTet-E2Ftr3.
A possible cause that lowers E2Ftr expressionmay be attributed to the
structures in AdTet-E2Ftr1 and AdTet-E2Ftr2 that restrict tTA
production. To verify this, we investigated whether Adhv used in
the bi-vector systemmay also increase E2Ftr expression in the single-
vector AdTet-E2Ftr1 and AdTet-E2Ftr2 by providing tTA in trans. SK-
MEL-2 cells were co-infected with Adhv plus AdTet-E2Ftr1, AdTet-
E2Ftr2, or AdTet-E2Ftr3. In the absence of Dox, Adhv increased E2Ftr
expression from AdTet-E2Ftr1 and AdTet-E2Ftr2 to levels similar to
AdTet-E2Ftr3 (Fig. 2C). As expected, E2Ftr expression from all three
vectors in Adhv co-infection was repressed in the presence of Dox
(Fig. 2C). These results indicate that tTA levels are not optimized in
AdTet-E2Ftr1 and AdTet-E2Ftr2 for maximal E2Ftr expression.
However, AdTet-E2Ftr3 does not require Adhv to increase E2Ftr
expression (Fig. 2B).
A truncated form of E2F-1 lacking the transactivation domain inhibits
Ad replication
We previously attempted to apply the CMV promoter to control
E2Ftr in Adv. However, such vector could not be rescued from
plasmids with Ad backbone in HEK-293 cells. It is likely that the
strong CMV-mediated high-level expression of E2Ftr may be toxic to
HEK-293 cells and prevent viral vector generation. We investigated
the effect of E2Ftr expression on Ad replication. HEK-293 cells were
infected at an MOI of 5 with AdTet-EGFP, AdTet-E2Ftr1, AdTet-E2Ftr2,
or AdTet-E2Ftr3 in the absence or presence of Dox (1 μg/ml) in cell
cultures, virus titers and E2Ftr expression were analyzed 3 days after
infection. We found that there was no difference in the titers of
AdTet-EGFP and AdTet-E2Ftr1 with or without Dox induction (Fig.
3A); AdTet-EGFP does not express E2Ftr and AdTet-E2Ftr1 expressed
very low levels of E2Ftr (Fig. 3B). The addition of Dox had little effect
on E2Ftr expression from AdTet-E2Ftr1, whereas Dox could repress
E2Ftr expression from AdTet-E2Ftr2 or AdTet-E2Ftr3-infected cells
(Fig. 3B). AdTet-E2Ftr2 and AdTet-E2Ftr3 produced higher levels of
E2Ftr in the absence of Dox (Fig. 3B). Inhibition of E2Ftr by Dox
resulted in increased AdTet-E2Ftr2 and AdTet-E2Ftr3 titers by 1000-
and 10,000-fold, respectively, which correlates with repressed virus
titers (Fig. 3A and B).
Because AdTet-E2Ftr3 produces the highest E2Ftr levels among the
three vectors, further studies focused on this vector. We assessed
virus plaque formation on HEK-293 plates transduced by AdTet-
E2Ftr3. HEK-293 cells, in the absence or presence of Dox (1 μg/ml),
were infected with AdTet-E2Ftr3 or AdTet-EGFP (control). One hour
later, unadsorbed viruses were removed and 0.5% of an agarose layer
with complete medium was added to the cells; plaque formation was
monitored over time. AdTet-EGFP plaques appeared after 4 days on
HEK-293 cell plates with or without Dox. No plaques were observed
with AdTet-E2Ftr3-infected cells up to 7 days; adding Dox allowed
AdTet-E2Ftr3 to form plaques (Fig. 3C).
Our results show that induced expression of E2Ftr strongly
inhibits Ad replication. E2Ftr may act as repressor of the Ad E2
promoter by blocking wt E2F-1 access to the promoter. Because the
Ad E2 gene is essential for viral DNA replication, overexpression of
E2Ftr is not only toxic to HEK-293 cells, but may also directly inhibit
Ad DNA replication.
Compare the effects of Dox and Tet on cell growth, E2Ftr expression,
and virus yield
The application of a low concentration of Dox (1 μg/ml) could not
strongly repress E2Ftr expression from the Tet-inducible vectors
(Figs. 2 and 3). Therefore, 1 μg/ml Dox cannot completely release the
E2Ftr-mediated inhibition of Ad replication; however, high doses of
Dox were reported to be toxic to mammal cells (Ermak et al., 2003;
Fig. 3. Effect of E2Ftr expression on Ad yield and lytic plaque formation. HEK-293 cells in either the absence or presence of Dox (1 μg/ml) were infected with AdTet-EGFP, AdTet-
E2Ftr1, AdTet-E2Ftr2, or AdTet-E2Ftr3 at an MOI of 5. After 72 h, cells were harvested and divided in two samples; one sample was used to conduct western blot analysis and the
second sample was used to determine virus titers. (A) ForWestern blot, a mAbmouse-antihuman E2F-1 was used to detect E2Ftr.α-Actin was used to demonstrate equal loading for
each lane. (B) For virus titering, cultures were collected at 72 h after infection and went through three cycles of freezing and thawing to release viruses from the cells. Lysates were
serially diluted to determine the titers in HEK-293 cells. The dashed line shows the level of viruses added in the cultures. Each point represents the mean of three independent
experiments±standard deviation (SD; bars). (C) HEK-293 cells were cultured in the presence or absence of Dox (1 μg/ml) and infected with AdTet-EGFP or AdTet-E2Ftr3 at an MOI
of 5; a standard plaque assay was performed to assess formation of lytic plaques. A representative experiment is shown from the three performed.
340 J.G. Gomez-Gutierrez et al. / Virology 397 (2010) 337–345Fife and Sledge, 1998) and can decrease virus ampliﬁcation as well.
We previously used Tet to regulate a Tet-off expression system
(Zhou and Beaudet, 2000). Tet may be less toxic to HEK-293 cells.
We compared the toxicity of Dox versus Tet to HEK-293 cells using a
3-(4, 5-dimethylthiazol-2-)-2, 5-diphenyltetrazolium bromide
(MTT) assay. Dox is more toxic to HEK-293 cells, as 10 μg/ml of
Dox resulted in 50% of HEK-293 viable cells, while 80% of viable cells
were observed at the same concentration of Tet (Fig. 4A). The high
toxicity of Dox to HEK-293 cells could affect virus replication. We
compared the effect of different doses of Dox and Tet on E2Ftr
regulation. HEK-293 cells in presence of increasing doses of Dox or
Tet (0, 1, 5, and 10 μg/ml) were infected with AdTet-E2Ftr3 at an
MOI of 5 and E2Ftr expression was analyzed 24 h after infection. It
was found that E2Ftr expression levels declined concomitantly with
dose increase of Dox and Tet (Fig. 4B). Both drugs have similar
regulatory effects on E2Ftr expression at their respective doses and at
10 μg/ml showed higher repression of E2Ftr expression. Comparing
with Figs. 2B and 3B, more effective shutoff of E2Ftr with Dox and Tet
is achieved in Fig. 4B, likely because of a lower MOI applied and
earlier protein harvest.
Because Tet is less toxic than Dox to HEK-293 cells and both Tet
and Dox have similar regulatory effects on E2Ftr expression, we
further anticipated that the application of Tet could result in a
higher Ad yield. HEK-293 cells were infected with AdTet-E2Ftr3 at
different doses of Dox or Tet. Although virus yield increased
concomitantly with dose increases from both Dox and Tet, Tet
10 μg/ml resulted in nearly 10-fold higher virus titers than
treatment with Dox at the same concentration (Fig. 4C). These
results indicate that Tet induces higher AdTet-E2Ftr3 production as
compared to Dox.E2Ftr expression induces morphological changes in melanoma cells
Changes onmelanoma cell morphologywere inspected after E2F-1
or E2Ftr expressions. AdTet-E2Ftr3 was compared with the binary-
vector Ad-E2Ftr and Ad-E2F-1 expressing wt E2F-1. SK-MEL-28 cells
were uninfected (mock) or infected with Ad-LacZ, Ad-E2F-1, AdTet-
E2Ftr3, or Ad-E2Ftr with or without Adhv. At 24 h post-infection,
melanoma cell morphologywas inspected. Mock or cells infected with
Ad-LacZ or Ad-E2Ftr without the Adhv vector showed no or little
morphological changes. Light microscopic observations revealed
morphological changes in SK-MEL-28 cells infected with Ad-E2F-1,
Ad-E2Ftr plus Adhv, or AdTet-E2Ftr3 alone. Cells were characterized
by rounding and loss of adherence to the ﬂask. In addition to showing
large cytoplasmic projections, some cells developed a vesiculated
cytoplasm, associated with apoptotic cell death (Fig. 5). The results
suggest that AdTet-E2Ftr3 alone can induce apoptotic cell death as did
Ad-E2F-1 that expresses wt E2F-1, Ad-E2Ftr that requires an Adhv
vector.
AdTet-E2Ftr3-mediated cancer death via apoptosis
To conﬁrm that AdTet-E2Ftr3 induces cell death by apoptosis, the
vector was compared with Ad-E2F-1 or Ad-E2Ftr. SK-MEL-28 cells
were uninfected (mock) or infected with Ad-LacZ, Ad-E2F-1, AdTet-
E2Ftr3, Ad-E2Ftr, or Ad-E2Ftr plus Adhv. Induction of apoptosis was
conﬁrmed by detection of cleaved PARP, which is a substrate of
caspase-3. Both PARP and caspase-3 are well known as apoptosis
markers (Fernandes-Alnemri et al., 1994; Itoshima et al., 2000).
Melanoma cells infected with Ad-E2F-1, AdTet-E2Ftr3, or Ad-E2Ftr
with Adhv showed an apoptosis-speciﬁc PARP cleavage fragment
Fig. 4. Comparison between Dox and Tet in HEK-293 survival, E2Ftr regulation, and Ad
yield. (A) Toxicity of Dox vs Tet at 0, 1, 5, and 10 μg/ml of concentration was compared
in HEK-293 cells by an MTT assay at 72 h after drug treatments. Each point represents
the mean of three independent experiments±(SD; bars). (B) HEK-293 cells in the
presence of Dox or Tet at 0, 1, 5, and 10 μg/ml were infected with AdTet-E2Ftr3 at an
MOI of 5. At 24 h after infection, cell extracts were used for western blot assay and a
mAb mouse-antihuman E2F-1 was used to detect E2Ftr. α-Actin was used to
demonstrate equal loading for each lane. (C) HEK-293 cells were infected with
AdTet-E2Ftr3 at an MOI of 5. Ad yield was determined in the presence of Dox or Tet at 0,
1, 5, and 10 μg/ml of concentration. The cultures were collected 3 days after infection
and went through three cycles of freezing and thawing to release viruses from the cells.
Lysates were serially diluted to determine the titers in HEK-293 cells. The dashed line
shows the level of viruses added in the cultures. Each point represents the mean of
three independent experiments±(SD; bars).
341J.G. Gomez-Gutierrez et al. / Virology 397 (2010) 337–345(85–90 kDa) as well as a decrease in the proenzyme caspase-3/
cysteine protease (CP)P32, whereas cleavage of PARP and decrease of
caspase-3 were not present in mock or cells infected with Ad-LacZ or
Ad-E2Ftr alone (Fig. 6A). In addition to activation of the caspases
pathway, apoptosis was conﬁrmed by Hoechst staining. No changes
on nuclei morphology were observed in mock, Ad-LacZ, or Ad-E2Ftr
(alone)-infected cells. In contrast, signiﬁcant nuclei fragmentation
was observed in cells infected with AdTet-E2Ftr3, Ad-E2F-1, or Ad-
E2Ftr plus Adhv (Fig. 6B).
In apoptotic cells, the membrane phospholipid phosphatidylser-
ine (PS) is translocated from the inner leaﬂet to the outer leaﬂet ofthe plasma membrane, thereby exposing PS to the external cellular
environment. Annexin V is a dependent phospholipid-binding
protein having a high afﬁnity for PS and binds to cells with
exposed PS. We used an annexin V-phycoerythrin (PE) kit to
determine the percentage of cells undergoing apoptosis. AdTet-
E2Ftr3, Ad-E2F-1, and Ad-E2Ftr plus Adhv induced similar percen-
tages of apoptosis at 87%, 70%, and 86%, respectively. In contrast, no
signiﬁcant apoptosis was detected in mock, Ad-LacZ, or Ad-E2Ftr
(alone) infections (Fig. 6C). These results demonstrate that E2Ftr in
the single-vector system can induce cancer apoptosis as efﬁciently
as other vectors.
AdTet-E2Ftr3 strongly induces cancer cell death
After observing that Ad-E2F-1 and AdTet-E2Ftr3 induce similar
levels of apoptosis, we further compared the cytotoxic effect of these
vectors on cancer cells. Cell death was analyzed by MTT assay at day 3
post-infection. As expected, Ad-E2Ftr only induces cancer cell killing
in the presence of Adhv (Fig. 7A). AdTet-E2Ftr3 induced strong cancer
death (70%), signiﬁcantly better than wt E2F-1, which induced about
50% death (Fig. 7B). Mock and Ad-LacZ could not kill cancer cells in the
same conditions. The results clearly show that AdTet-E2Ftr3 as a novel
vector does not require a helper virus to induce cancer death. In
addition, AdTet-E2Ftr3 can more efﬁciently destroy cancer cells than
the Adv expressing wt E2F-1.
Discussion
Despite wt E2F-1 efﬁciently inducing apoptosis in cancer cells in
vitro and in vivo (Dong et al., 1999, 2002; Elliott et al., 2001; Itoshima
et al., 2000; Vorburger et al., 2005), its oncogenic property of
promoting cell proliferation by its ability to stimulate gene expression
limits its application in cancer gene therapy. This concern could be
avoided by using a E2Ftr that lacks the transactivation domain and cell
cycle-promoting effects (Bell et al., 2006; Fan and Bertino, 1997).
Studies have shown that E2Ftr is a potent inducer of apoptosis but is
unable to promote cell cycle progression (Fan and Bertino, 1997;
Hsieh et al., 1997; Melillo et al., 1994).
We previously tried to construct an Adv encoding E2Ftr with the
CMV promoter. However, such vector could not be generated, likely
because E2Ftr is toxic to Ad host HEK-293 cells and/or inhibits vector
ampliﬁcation. For this reason, we developed binary- and single-
inducible Adv. In the binary system, the helper vector Adhv expresses
tTA to activate the E2Ftr gene carried in other vector. In a single-vector
system, the tTA expressing cassette and E2Ftr gene are incorporated
into one vector (Fig. 1). We constructed three single vectors, AdTet-
E2Ftr1, AdTet-E2Ftr2, and AdTet-E2Ftr3, and compared themwith the
binary vector.
We observed that both AdTet-E2Ftr1 and AdTet-E2Ftr2 expressed
low levels of E2Ftr and AdTet-E2Ftr3 expressed the highest E2Ftr level
(Fig. 2B). The expression cassettes in AdTet-E2Ftr1 and AdTet-E2Ftr2
are closely connected, although they are in a different orientation and
order. When Adhv, which can provide tTA in trans, was applied with
AdTet-E2Ftr1 and AdTet-E2Ftr2 in infection, E2Ftr expression signif-
icantly increased to the levels observed with AdTet-E2Ftr3 (Fig. 2C).
Adhv could not increase E2Ftr expression from AdTet-E2Ftr3 (Fig. 2B).
The only difference between AdTet-E2Ftr2 and AdTet-E2Ftr3 is the
400-bp fragment inserted in the later vector. The results suggest that
the structures of the E2Ftr cassette and the transcription activator tTA
cassette in a single vector may affect each other when they are closely
connected and cause inefﬁcient E2Ftr induction. For maximal
therapeutic gene expression, the optimum structure should be
derived when an inducible single-vector system is applied to express
toxic genes.
E2F-1 is a transcription factor that was ﬁrst described as a nuclear
activity that binds to the Ad E2 promoter (Kovesdi et al., 1986a,
Fig. 5. Effect of E2F-1 or E2Ftr expressions on melanoma cell morphology. SK-MEL-28 cells were uninfected (mock) or infected at an MOI of 100 with Ad-LacZ, Ad-E2F-1, AdTet-
E2Ftr3, or Ad-E2Ftr alone or co-infected with Adhv at an MOI of 5. After 24 h, cell morphology was analyzed by light microscopy. Apoptotic cells are indicated by arrowhead;
vesiculated cells are indicated by arrow. Pictures were taken with bright-ﬁeld optics at ×40 magniﬁcation.
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binding of E2F to the Ad promoter is important for expression of the
virus E2 gene that is directly involved in viral DNA replication (Huang
and Hearing, 1989). This binding is dependent on a region of E2F-1
between amino acids 284 and 358 (Helin and Harlow, 1994). The
E2Ftr used in our study maintains this DNA binding region but lacks
the transcription activation domain. We observed that E2Ftr signif-
icantly affects virus yield. High levels of E2Ftr of AdTet-E2Ftr3
correlate with signiﬁcantly low virus production, especially when
withdrawing Dox induces E2Ftr. In a viral plaque assay, we observed
that plaques only formed in the presence of Dox in HEK-293 cells
infected with AdTet-E2Ftr3, while the control AdTet-EGFP formed
plaques with or without Dox. The results clearly show that E2Ftr
strongly inhibits Ad replication that explains whywe previously could
not rescue an Ad-encoding E2Ftr controlled by the strong CMV
promoter. E2Ftr protein may competitively bind to the viral E2a
promoter and inhibits Ad vector ampliﬁcation; the protein may also
repress expression of cellular genes that are required for efﬁcient Ad
replication, such as cyclin E (Zheng et al., 2008). Furthermore, it is
reasonable to believe that E2Ftr introduced into cancer cells can bind
to and repress the promoters of genes that are normally activated by
wt E2F for cell proliferation. Thus, we expect that using E2Ftr can
inhibit tumor growth more efﬁciently than wt E2F-1. This hypothesis
is supported by our animal studies of a melanoma xenograft model
(J.G. Gomez-Gutierrez, et al. manuscript submitted).
The commercial distributor of the Tet-off system (Clontech
Laboratories, Inc., Mountain View, CA) recommends using a 1 μg/ml
Dox concentration to inhibit the inducible promoter. However, to
achieve efﬁcient regulation of transgene expression, higher Dox
concentrations are necessary (Figs. 2–4). However, higher Dox
concentrations are toxic to mammals cells (Ermak et al., 2003) and
induce cell death in vitro and in vivo (Fife and Sledge, 1998). We
compared Dox and Tet and found them to have similar regulatory
effects on E2Ftr expression, except that Dox was more toxic to HEK-293 cells (Fig. 4A). When Tet was used instead of Dox, approximately
10-fold higher titers were produced (Fig. 4C).
Our studies have shown that when Tet-off activator tTA is
incorporated into the same Ad vector to induce E2Ftr, the vector
structures signiﬁcantly affect therapeutic gene expression. We have
shown that separation of the tTA cassette from the therapeutic gene
cassette with a 400-bp DNA fragment greatly increases the E2Ftr
protein level. We further demonstrated that AdTet-E2Ftr3-mediated
high-level expression of E2Ftr is toxic to cancer cells and efﬁciently
induces apoptotic cancer cell death by increasing PARP cleavage and
decreasing the proenzyme caspase-3/CPP32 (Figs. 6 and 7).
This is the ﬁrst report of the creation of a single-Adv system
expressing the cancer-killing E2Ftr gene. This study demonstrates that
we can optimize vector structures to create viral vectors expressing
high levels of toxic genes. Because E2Ftr is so toxic to cancer cells,
AdTet-E2Ftr3 may have an enormous advantage in cancer gene
therapy. Many genes are selected for potential cancer gene therapy
based on their properties of toxicity to destroy cancer cells. These
genes are also likely to be toxic to viral vector host cells. Thereby, Adv,
as well as other viral vectors intended to express powerful therapeutic
genes, are generally difﬁcult to generate. The approach reported in
this study may be applied in constructions of Ad and other viral
vectors for expression of other toxic genes.
Materials and methods
Cell lines and culture conditions
Humanmelanoma cell lines SK-MEL-2 and SK-MEL-28 and human
embryonic kidney cell line HEK-293 were purchased from the
American Type Culture Collection (Rockville, MD). SK-MEL-2 and
SK-MEL-28 cell lines were cultured in α-minimal essential medium
(α-MEM). HEK-293 cells were cultured in minimal essential medium-
α (MEM-α) supplemented with 10% heat-inactivated fetal bovine
Fig. 6. Evaluation of apoptosis induced by three different Adv expressing E2F-1 or E2Ftr. SK-MEL-28 cells were uninfected (mock) or infected at anMOI of 100 with Ad-LacZ, Ad-E2F-
1, AdTet-E2Ftr3, or Ad-E2Ftr alone or co-infection with Adhv at an MOI of 5. After 72 h, cells were analyzed for activation of the caspases pathway and apoptosis. (A) Western blot
was used to detect activation of the caspases pathway, a mAbmouse-antihuman E2F-1 was used to detect E2Ftr, a mAbmouse-antihuman PARP was used to detect PARP, and a mAb
mouse-antihuman caspase-3/CPP3 was used to detect caspase-3. α-Actin was used to demonstrate equal loading for each lane. (B) Hoechst staining was performed by adding
Hoechst 33258 dye to a ﬁnal concentration of 10 μM to each well in the 24-well plate. Condensation and fragmentation of nuclei (examples indicated by white arrows) were
observed under a ﬂuorescence microscope (Olympus Microsystems) at ×20 magniﬁcation. (C) For annexin V staining, cells were stained with annexin V-PE and 7-Amino-
actinomycin D (7-AAD); positive cells for annexin V-PE and 7-AAD staining were analyzed by FACScan ﬂow cytometer with FlowJo software. Similar results were obtained in three
independent experiments. A representative experiment is shown.
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reagents were obtained from Gibco BRL (Bethesda, MD). Cells were
cultured in a 5% CO2 incubator at 37 °C and the medium was changed
every 2 or 3 days.
Recombinant Ad vectors
Eight replication-defective Adv were used. The Ad5CMV-E2F-1
(Ad-E2F-1) vector was deleted in the E1 subunit and contained the
transgene E2F-1 under the control of the CMV promoter (Dong et al.,
2002). Ad5CMV-LacZ (Ad-LacZ) vector was deleted in the E1 subunit
and contained the transgene nuclear-localized β-galactosidase under
the control of the CMV promoter and was used as a control as
described (Dong et al., 2002). The Ad-E2Ftr expresses a truncated E2F-
1 protein, which retains the E2F-1 DNA binding domain but lacks itstransactivation domain. The expression of E2Ftr is under the
regulation of Tet-responsive element (TRE) and the Tet-controlled
transactivator virus (Adeno-X Tet-Off) was used as a helper virus
(Adhv) to activate the Tet-responsive promoter (Dong et al., 2007;
Hao et al., 2007). The other four Adv (AdTet-EGFP, AdTet-E2Ftr1,
AdTet-E2Ftr2, and AdTet-E2Ftr3) were constructed by us based on the
widely used Ad-Easy system (MP Biomedicals, Irvine, CA).
AdTet-EGFPwas constructed as follows. The tTA protein and poly A
signal (tTA/polyA) fragment was excised from pUHD15-1 with XbaI/
HindIII and subcloned into pShuttle-tTA/polyA. The phcmv sequence
was then excised from pBH72 with XhoI/HindIII and ligated into
pΔE1sp1A, resulting in pΔE1sp1A-phcmv. The phcmv fragment was
excised from pΔE1sp1A-phcmv with BamHI and subcloned into
pShuttle-tTA in the BglII site, resulting in pShuttle-tTA/phcmv. Once
this plasmid was obtained, a multiple cloning sequence (MCS)
Fig. 7. Assessment of melanoma cell killing activity from Adv encoding E2F-1 or E2Ftr.
SK-MEL-28 cells were infected with (A) Ad-E2Ftr alone (at an MOI of 100) or co-
infected with Adhv at an MOI of 5 or (B) uninfected (mock) or infected at an MOI of
100 with Ad-LacZ, Ad-E2F-1, and AdTet-E2Ftr3. At 72 h after infection, cell viability
was analyzed by MTT assay; each point represents the mean of three independent
experiments±(SD; bars).
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upstream of tTA. The CMV promoter was ampliﬁed by polymerase
chain reaction (PCR) from pShuttle-CMV with primers containing the
restriction sites NheI and NotI, respectively. Primer sequences were:
5′-GCTAGCGCGTTACATAACTTACGGTA-3′ and
5′-GCGGCCGCGATCTGACGGTTCACTAAA-3′.
After PCR assay, a 530-bp product was obtained and ligated in the
sites NheI/NotI from pShuttle-tTA/phcmv, resulting in the plasmid
pShuttle-CMV/tTA/phcmv. EGFP was ampliﬁed by PCR from pIRES-
EGFP using primers containing the restriction sites BglII and AscI,
respectively. Primer sequences were:
5′-TATAGATCTACATGGTGAGCAAGGGCGAGG-3′ and
5′-TGGCGCGCCGCCAGCTGGTTCTTTCCGCCT-3′.
After the PCR assay, a 1.0 kb fragment was obtained and ligated in
the BglII/AscI sites from pShuttle-CMV/tTA/phcmv, resulting in the
plasmid pShuttle-CMV/tTA/phcmv-EGFP.
AdTet-EGFP was a model for the construction of AdTet-E2Ftr1.
E2Ftr was excised from plasmid pAdstE2Ftr with BamHI and cloned in
the BglII restriction site from pShuttle-CMV/tTA/phcmv, resulting in
the plasmid pShuttle-CMV/tTA/phcmv-E2Ftr.
AdTet-E2Ftr2 construction method
The phcmv/E2Ftr/polyA cassette was removed from the pAd-
stE2Ftr plasmid with the enzymes XhoI/HindIII and was ligated into
a pShuttle vector in the SalI/HindIII sites, resulting in pShuttle-
phcmv/E2Ftr/polyA. The CMV/tTA/polyA cassette was excised
twice. It was ﬁrst excised from pUHD15-1 with XhoI/HindIII and
ligated in the XhoI/HindIII sites from pBluescript II KS+/
−(Fermentas Inc., Glen Burnie, MD), resulting in pBSII-CMV/tTA/
polyA. The CMV/tTA/polyA cassette was excised again from pBSII-
CMV/tTA/polyA with XhoI/NotI and ligated in the XhoI/NotI sites
from pShuttle-phcmv/E2Ftr/polyA, resulting in pShuttle-phcmv/
E2Ftr/polyA-CMV/tTA/polyA.AdTet-E2Ftr3 construction method
A 400-bp fragment containing a poly A signal of bovine growth
hormone (BGHpA) and f1 origin was excised from the pcDNA3.1
(+/−) plasmid (Invitrogen) with XbaI/PsiI and ligated in the XbaI/
EcoRV sites from pShuttle-phcmv/E2Ftr/polyA with the purpose of
replacing the SV40 poly A sequence for BGHpA. The resulting plasmid
was named pShuttle-phcmv/E2Ftr/BGHpA. The CMV/tTA/polyA
fragment was then removed from pBSII-CMV/tTA/polyA with XhoI/
NotI and ligated in the XhoI/NotI sites from pShuttle-phcmv/E2Ftr/
BGHpA, resulting in pShuttle-phcmv/E2Ftr/BGHpA-CMV/tTA/polyA.
These 4 shuttle vectors were used to generate recombinant Ads,
according to the manufacturer's instructions accompanying the Ad-
Easy system. Virus particles from AdTet-E2Ftr1, AdTet-E2Ftr2, and
AdTet-E2Ftr3 were rescued from the host HEK-293 cells in the
presence of 1 μg/ml of Dox. Titers were determined using Adeno-X
rapid titer kit (Clontech) in the presence of Tet (10 μg/ml).
For infections, 5×105 SK-MEL-2 or SK-MEL-28 cells were plated in
60-mm tissue culture plates. The following day, the media were
removed and the Adv were added in 0.5 ml of α-MEM at indicated
concentrations of MOI plaque-forming units/cell. Mock infection was
performed by treatment of cells with vehicle (media) only. After 1 h of
incubation at 37 °C, the medium was removed and 3 ml of fresh α-
MEM with 5% FBS was added. Cells were harvested at speciﬁc time
points for analysis.
Western blot analysis
Cells were harvested and lysed in a radio immunoprecipitation
assay (RIPA) buffer as described previously (Gomez-Gutierrez et al.,
2006). Cell lysates were centrifuged and protein concentration was
determined by Detergent Compatible (DC) protein assay (Bio-Rad,
Hercules, CA). Equal amounts of cellular proteinwere electrophoresed
in 10% sodium dodecyl sulfate–polyacrylamide gels (SDS–PAGEs) and
transferred to Hybond-polyvinylidene diﬂuoride (PVDP) membranes
(Amersham, Arlington Heights, IL). The membranes were ﬁrst
incubated with the following primary antibodies (Abs): mouse-
antihuman-E2F-1 monoclonal (m)Ab (Santa Cruz Biotech, Santa Cruz,
CA) and rabbit-antihuman-α-actin polyclonal (p)Ab, mouse-antihu-
man-CPP32 mAb (Transduction Laboratories, Lexington, KY), and
mouse-antihuman-PARP mAb (Calbiochem, San Diego, CA). Next, the
membranes were incubated with antimouse immunoglobulin (Ig) or
anti-rabbit Ig, peroxidase-linked, species-speciﬁc whole Abs (Amer-
sham). Electrochemiluminescent (ECL) reagents were used to detect
the signals according to the manufacturer's instructions (Amersham).
Cellular proliferation
Cell proliferation was assessed at 3 days after drug treatment (Dox
or Tet) or infection by measuring the conversion of the tetrazolium
salt (MTT) to formazan according to the manufacturer's instructions
(Boehringer Mannheim, Indianapolis, IN) and as was reported
previously (Gomez-Gutierrez et al., 2006). The supernatant from
each plate was collected for measurement of absorbance at a
wavelength of 570 nm. The results were expressed as the percentage
of live cells.
Ad replication and titering
2×105 HEK-293 cells were pleated in a 6-well plate in the absence
or presence of Dox (1 μg/ml). The next day, cells were infected with
AdTet-EGFP, AdTet-E2Ftr1, AdTet-E2Ftr2, or AdTet-E2Ftr3 at an MOI
of 5. After 1 h of infection, unabsorbed virus particles were removed
and fresh medium was added with or without Dox (1 μg/ml). The
cultures were collected after 3 days; cells went through three cycles of
freezing and thawing to release viruses from the cells. Lysates were
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infective unit (IFU) measurement.
Melanoma cell morphology
In a 12-well plate, 1×105 SK-MEL-28 cells were uninfected (mock)
or infected with Ad-LacZ, Ad-E2F-1, Ad-E2Ftr, Ad-E2Ftr plus Adhv (5
MOI), or AdTet-E2Ftr at an MOI of 100. After 24 h, cell morphology
was analyzed by light microscopy (Olympus Microsystems, Redwood
City, CA). Pictures were taken in bright-ﬁeld at ×40 magniﬁcation.
Detection of apoptosis
Hoechst staining was performed by adding Hoechst dye to a ﬁnal
concentration of 10 μM to each well in the 24-well plate. Apoptotic
cell death was determined by observation of apoptotic nuclei (i.e.,
fragmentation and condensation of nuclei) following Hoechst 33258
staining for 10 min at 37 °C. Nuclei morphology was observed under a
ﬂuorescence microscope (Olympus Microsystems).
Annexin V staining
Annexin staining was performed as described previously (Gomez-
Gutierrez et al., 2006) and according to the manufacturer's instruc-
tions (Annexin V-PE Apoptosis Kit, Pharmingen, San Diego CA). Cells
were analyzed by ﬂuorescence-activated cell sorter scan (FACScan)
ﬂow cytometer (Becton Dickinson, Franklin Lakes, NJ) with FlowJo
software (Tree Star Inc., Ashland, OR).
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